Treatment of Cancer Pain by Targeting Cytokines
Open Access
- 1 January 2015
- journal article
- review article
- Published by Wiley in Mediators of Inflammation
- Vol. 2015 (1) , 984570
Abstract
Inflammation is one of the most important causes of the majority of cancer symptoms, including pain, fatigue, cachexia, and anorexia. Cancer pain affects 17 million people worldwide and can be caused by different mediators which act in primary efferent neurons directly or indirectly. Cytokines can be aberrantly produced by cancer and immune system cells and are of particular relevance in pain. Currently, there are very few strategies to control the release of cytokines that seems to be related to cancer pain. Nevertheless, in some cases, targeted drugs are available and in use for other diseases. In this paper, we aim to review the importance of cytokines in cancer pain and targeted strategies that can have an impact on controlling this symptom.Keywords
This publication has 86 references indexed in Scilit:
- Statin Use and Pain in Older People with Cancer: A Cross‐Sectional StudyJournal of the American Geriatrics Society, 2014
- Targeting peripheral opioid receptors to promote analgesic and anti-inflammatory actionsFrontiers in Pharmacology, 2013
- Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathyCytokine, 2012
- Prospective Study Evaluating the Plasma Concentrations of Twenty-six Cytokines and Response to Morphine Treatment in Cancer Patients2011
- The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guidelineJournal of Neuro-Oncology, 2009
- Chemokines, chemokine receptors and painTrends in Immunology, 2005
- The molecular complexity of glucocorticoid actions in inflammation — a four-ring circusCurrent Opinion in Pharmacology, 2004
- Targeted etanercept for treatment-refractory pain due to bone metastasis: Two case reportsClinical Therapeutics, 2003
- The molecular dynamics of pain controlNature Reviews Neuroscience, 2001
- Substance p receptor (neurokinin-1)-expressing neurons in lamina i of the spinal cord encode for the intensity of noxious stimulation: a c-fos study in ratNeuroscience, 1999